The role of microvesicles in cancer progression and drug resistance

Biochemical Society Transactions

Volumn 41, Issue 1, 2013, Pages 293-298

  Jorfi, Samireh ^a   Inal, Jameel M ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Microvesicle; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CASPASE 3; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P INHIBITOR; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P53;

ACTIN FILAMENT; ANGIOGENESIS; APOPTOSIS; CALCIUM CELL LEVEL; CANCER GROWTH; CANCER RESISTANCE; CELL COMMUNICATION; CELL SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; DEPOLYMERIZATION; DRUG TRANSPORT; ENZYME ACTIVATION; HUMAN; IMMUNOLOGICAL TOLERANCE; MEMBRANE VESICLE; METASTASIS; MICROVESICLE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT;

APOPTOSIS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; GENES, P53; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; P-GLYCOPROTEIN;

EID: 84873180150     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120273     Document Type: Conference Paper

References (56)

1. Hugel, B., Martinez, M. C., Kunzelmann, C. and Freyssinet, J. M. (2005) Membrane microparticles: two sides of the coin. Physiology 20, 22-27 (Pubitemid 40363367)
2. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A. and Ratajczak, M. Z. (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (Pubitemid 44264090)
3. Yuan, A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B. and Farber, D. B. (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 4, e4722
4. Zitvogel, L., Fernandez, N., Lozier, A., Wolfers, J., Regnault, A., Raposo, G. and Amigorena, S. (1999) Dendritic cells or their exosomes are effective biotherapies of cancer. Eur. J. Cancer 35(Suppl. 3), S36-S38
5. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T. et al. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297-303 (Pubitemid 32224344)
6. Théry, C., Boussac, M., Véron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J. and Amigorena, S. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166, 7309-7318 (Pubitemid 32525606)
7. Childs, S. and Ling, V. (1994) The MDR superfamily of genes and its biological implications. Important Adv. Oncol. 21-36
8. Sharom, F. J. (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9, 105-127 (Pubitemid 351560534)
9. Fardel, O., Lecureur, V. and Guillouzo, A. (1996) The P-glycoprotein multidrug transporter. Gen. Pharmacol. 27, 1283-1291 (Pubitemid 26419684)
10. Ak, Y., Demirel, G. and Gulbas, Z. (2007) MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. Nucl. Med. Commun. 28, 541-546 (Pubitemid 46848646)
11. Berger, W., Setinek, U., Hollaus, P., Zidek, T., Steiner, E., Elbling, L., Cantonati, H., Attems, J., Gsur, A. and Micksche, M. (2005) Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J. Cancer Res. Clin. Oncol. 131, 355-363 (Pubitemid 40674620)
12. Schifferli, J. A. (2011) Microvesicles are messengers. Semin. Immunopathol. 33, 393-394
13. Del Conde, I., Shrimpton, C. N., Thiagarajan, P. and López, J. A. (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106, 1604-1611 (Pubitemid 41208572)
14. Ay, C., Freyssinet, J. M., Sailer, T., Vormittag, R. and Pabinger, I. (2009) Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb. Res. 123, 724-726
15. Castellana, D., Toti, F. and Freyssinet, J. M. (2010) Membrane microvesicles: macromessengers in cancer disease and progression. Thromb. Res. 125(Suppl. 2), S84-S88
16. Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A. and D'Souza-Schorey, C. (2010) Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123, 1603-1611
17. English, D., Garcia, J. G. and Brindley, D. N. (2001) Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49, 588-599 (Pubitemid 32146422)
18. Janowska-Wieczorek, A., Majka, M., Kijowski, J., Baj-Krzyworzeka, M., Reca, R., Turner, A. R., Ratajczak, J., Emerson, S. G., Kowalska, M. A. and Ratajczak, M. Z. (2001) Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98, 3143-3149
19. Sarkar, A., Mitra, S., Mehta, S., Raices, R. and Wewers, M. D. (2009) Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS ONE 4, e7140
20. Distler, J. H., Huber, L. C., Gay, S., Distler, O. and Pisetsky, D. S. (2006) Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39, 683-690 (Pubitemid 44964371)
21. Chironi, G. N., Boulanger, C. M., Simon, A., Dignat-George, F., Freyssinet, J. M. and Tedgui, A. (2009) Endothelial microparticles in diseases. Cell Tissue Res. 335, 143-151
22. Lee, T. H., D'Asti, E., Magnus, N., Al-Nedawi, K., Meehan, B. and Rak, J. (2011) Microvesicles as mediators of intercellular communication in cancer: the emerging science of cellular 'debris'. Semin. Immunopathol. 33, 455-467
23. Al-Nedawi, K., Meehan, B. and Rak, J. (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8, 2014-2018
24. Shedden, K., Xie, X. T., Chandaroy, P., Chang, Y. T. and Rosania, G. R. (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 63, 4331-4337 (Pubitemid 36950999)
25. Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W. and Howell, S. B. (2005) Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol. Cancer Ther. 4, 1595-1604 (Pubitemid 41556443)
26. Elward, K., Griffiths, M., Mizuno, M., Harris, C. L., Neal, J. W., Morgan, B. P. and Gasque, P. (2005) CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280, 36342-36354 (Pubitemid 41633908)
27. Sims, P. J., Faioni, E. M., Wiedmer, T. and Shattil, S. J. (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and expresses prothrombinase activity. J. Biol. Chem. 268, 18205-18212 (Pubitemid 19005097)
28. Abrahams, V. M., Straszewski, S. L., Kamsteeg, M., Hanczaruk, B., Schwartz, P. E., Rutherford, T. J. and Mor, G. (2003) Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 63, 5573-5581 (Pubitemid 37139880)
29. Pegtel, D. M., van de Garde, M. D. and Middeldorp, J. M. (2011) Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim. Biophys. Acta 1809, 715-721
30. Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G. and Rivoltini, L. (2006) Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res. 66, 9290-9298 (Pubitemid 44521151)
31. Taraboletti, G., D'Ascenzo, S., Borsotti, P., Giavazzi, R., Pavan, A. and Dolo, V. (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 160, 673-680 (Pubitemid 34160345)
32. Janowska-Wieczorek, A., Wysoczynski, M., Kijowski, J., Marquez-Curtis, L., Machalinski, B., Ratajczak, J. and Ratajczak, M. Z. (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer 113, 752-760 (Pubitemid 40101256)
33. Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M. L., Schmittgen, T. D., Nana-Sinkam, S. P. et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3, e3694
34. Scholz, T., Temmler, U., Krause, S., Heptinstall, S. and Losche, W. (2002) Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb. Haemostasis 88, 1033-1038 (Pubitemid 36018792)
35. Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G. and Rivoltini, L. (2007) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 67, 2912-2915 (Pubitemid 46724823)
36. Van Doormaal, F. F., Kleinjan, A., Di, N. M., Buller, H. R. and Nieuwland, R. (2009) Cell-derived microvesicles and cancer. Neth. J. Med. 67, 266-273
37. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J. and Raposo, G. (2002) The biogenesis and functions of exosomes. Traffic 3, 321-330 (Pubitemid 34461042)
38. Jaiswal, R., Gong, J., Sambasivam, S., Combes, V., Mathys, J. M., Davey, R., Grau, G. E. and Bebawy, M. (2012) Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J. 26, 420-429
39. Freyssinet, J. M. and Dignat-George, F. (2005) More on: measuring circulating cell-derived microparticles. J. Thromb. Haemostasis 3, 613-614 (Pubitemid 41632898)
40. Gottesman, M. M. (2002) Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615-627 (Pubitemid 34177898)
41. Lage, H. (2008) An overview of cancer multidrug resistance: a still unsolved problem. Cell. Mol. Life Sci. 65, 3145-3167
42. Crowley, E. and Callaghan, R. (2010) Multidrug efflux pumps: drug binding - gates or cavity? FEBS J. 277, 530-539
43. Andersson, B. S., Mroue, M., Britten, R. A., Farquhar, D. and Murray, D. (1995) Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line. Acta Oncol. 34, 247-251
44. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E. and Jacks, T. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266, 807-810 (Pubitemid 24359290)
45. Lowe, S. W., Bodis, S., Bardeesy, N., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Jacks, T., Pelletier, J. and Housman, D. E. (1994) Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harbor Symp. Quant. Biol. 59, 419-426
46. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (Pubitemid 23289454)
47. Lowe, S. W. and Ruley, H. E. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535-545 (Pubitemid 23125255)
48. Bebawy, M., Morris, M. B. and Roufogalis, B. D. (2001) Selective modulation of P-glycoprotein-mediated drug resistance. Br. J. Cancer 85, 1998-2003 (Pubitemid 34775339)
49. Bebawy, M., Morris, M. B. and Roufogalis, B. D. (1999) A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles. Anal. Biochem. 268, 270-277 (Pubitemid 29147142)
50. Luqmani, Y. A. (2005) Mechanisms of drug resistance in cancer chemotherapy. Med. Princ. Pract. 14(Suppl. 1), 35-48 (Pubitemid 41161048)
51. Leslie, E. M., Deeley, R. G. and Cole, S. P. (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204, 216-237 (Pubitemid 40552845)
52. Combes, V., Coltel, N., Alibert, M., van Eck, M., Raymond, C., Juhan-Vague, I., Grau, G. E. and Chimini, G. (2005) ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J. Pathol. 166, 295-302 (Pubitemid 40051681)
53. Levchenko, A., Mehta, B. M., Niu, X., Kang, G., Villafania, L., Way, D., Polycarpe, D., Sadelain, M. and Larson, S. M. (2005) Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc. Natl. Acad. Sci. U. S. A. 102, 1933-1938 (Pubitemid 40261990)
54. Bebawy, M., Combes, V., Lee, E., Jaiswal, R., Gong, J., Bonhoure, A. and Grau, G. E. (2009) Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23, 1643-1649
55. Mellor, H. R. and Callaghan, R. (2011) Accumulation and distribution of doxorubicin in tumour spheroids: the influence of acidity and expression of P-glycoprotein. Cancer Chemother. Pharmacol. 68, 1179-1190
56. Van der Vos, K. E., Balaj, L., Skog, J. and Breakefield, X. O. (2011) Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell. Mol. Neurobiol. 31, 949-959